dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· June 1, 2026

The S&P 500 just flashed a rare warning signal last seen in dot-com bubble. Crashproof your wealth now

View original at finance.yahoo.com
The S&P 500 just flashed a rare warning signal last seen in dot-com bubble. Crashproof your wealth now Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The S&P 500 CAPE ratio has recently climbed to roughly 41.33, a level reached only twice in the past century.

    60% confidence
  • Since 1871, Shiller's CAPE ratio has exceeded 24 on only six occasions, with the first five occurring immediately prior to major market downturns.

    60% confidence
  • Higher CAPE ratios have historically been associated with lower long-term stock market returns.

    60% confidence
  • A market crash or recession is not necessarily imminent despite the elevated CAPE ratio.

    60% confidence
  • The CAPE ratio has not been a reliable indicator of when exactly a market downturn will begin.

    60% confidence
  • A current CAPE ratio of 41.33 means investors are paying roughly $41.33 for every $1 of inflation-adjusted earnings generated over the previous 10 years.

    60% confidence
  • The CAPE ratio is best used as a risk management tool for assessing portfolio diversification rather than as a market-timing tool.

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,995
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,995 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
The S&P 500 just flashed a rare warning signal last seen in dot-com bubble. Crashproof your wealth now: Source | Via News | fr.via.news